The groundbreaking application of AI and brain implants offers hope to many paralyzed individuals, paving the way for potential advancements in medical science and improving ... Jul 31
Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem ... Aug 11
The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials. ... Aug 08
Latest Pharma Update... Aug 23
The new service also aims to maximize yield and minimize waste of API ... Jul 16
The company also announced the planned initiation of the innovative CONNEX Phase III clinical trial program assessing the safety and efficacy of BI 425809 ... May 27
The joint research is aimed to create new services for drug development and clinical trials ... Mar 20
DalCor Pharmaceuticals today announced the initiation of dal-COVID, a Phase 2 proof-of-concept study for dalcetrapib as a potential oral anti-viral treatment ... Jan 11
AIM ImmunoTech Inc. announced today that the post-COVID-19 “Long Hauler†portion of the active AMP-511 Expanded Access Program (EAP) protocol received approval ... Dec 26
Serum Institute Of India And Dynavax, today jointly announced that the first participants have been dosed in the Phase 1 part of the Phase 1/... Dec 24
The broad-spectrum antiviral therapeutic, 'hzVSF-v13(humanized Virus Suppressing Factor)' being developed by ImmuneMed, is on track to progress as a treatment for the ... Dec 21
Greenwich LifeSciences collaborates with Westport Bio to in-license a pre-clinical coronavirus vaccine program that is currently at the stage of pre-clinical animal ... Dec 16
Harbour BioMed, and Utrecht University today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the ... Dec 15
Kintor Pharmaceutical Limited is pleased to update the preliminary analysis of Proxalutamide's clinical trial for the treatment of COVID-19.... Dec 12
Cerner Corporation, today announced an investment in Elligo Health Research, a leading integrated research organization that enables clinical trials with nationwide community-based health care ... Dec 09
Cabaletta Bio, today announced that the first patient has been dosed in the DesCAARTesâ„¢ Phase 1 clinical trial of DSG3-CAART for the treatment of ... Dec 09
Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
Athira Pharma, today announced that patient dosing has begun in ACT-AD, a Phase 2 randomized, placebo-controlled study of ATH-1017 in patients with ... Dec 02
Vyriad, Inc. announced today the addition of new clinical sites in its ongoing clinical study evaluating an intravesical oncolytic measles virus therapy in bladder cancer ... Dec 02
BHV3000-310 is a double-blind, randomized trial evaluating the safety and efficacy of rimegepant in the acute treatment of migraine.... Nov 23
The Tamil Nadu Health Department has said an exhaustive Covid-19 vaccine delivery plan will be unveiled once their clinical trials are completed.... Nov 21
Arbutus Biopharma Corporation a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection as well ... Nov 16
Dr Reddy's will conduct the clinical trials and, subject to approval, distribute the finished vaccine in India... Nov 16
Cynata Therapeutics announces that the Phase 3 Osteoarthritis Clinical Trial..... Nov 12
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
-Advertisements-
Friday, April 26, 2024
